Full-Time

Director – State and Local Tax

Posted on 4/16/2025

Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

No salary listed

Expert

Company Historically Provides H1B Sponsorship

Summit, NJ, USA + 2 more

More locations: Princeton, NJ, USA | Lawrence Township, NJ, USA

Hybrid work model with at least 50% onsite presence required.

Category
Tax Accounting
Accounting
Required Skills
Power BI
SAP Products
Tableau
Requirements
  • Bachelor's degree in accounting, finance, or a related field; preferably with a Masters of Tax, JD and/or CPA license.
  • 15+ years of state and local tax provision and compliance experience working in a complex manufacturing environment or in the pharmaceutical industry, preferable with 2+ years of public accounting experience.
  • Strong people manager and talent development skills.
  • In-depth knowledge of state and local tax laws, regulations, proven experience managing complex SALT issues and audits, and preferable ASC 740 experience.
  • Strong research, analytical and problem-solving skills, with the ability to interpret and apply tax laws and regulations.
  • Commitment to staying current with changes in tax laws and regulations through ongoing education and professional development.
  • Experience in developing and implementing tax strategies that align with business objectives.
  • Proficiency in Microsoft Office Suite and a solid technology background, preferable with knowledge of SAP, OneSource Provision (knowledge of TaxStream is very beneficial), intelligent automation such as Alteryx, RPA, Power BI and Tableau.
  • Proven ability to manage multiple projects and deadlines effectively.
  • Ability to negotiate effectively with tax authorities, auditors and outside advisors.
  • Strong sense of ethics and integrity in handling sensitive tax information.
  • Excellent communication and interpersonal skills to effectively collaborate with internal and external stakeholders, strong attention to detail and ability to work under tight deadlines.
Responsibilities
  • Oversee all aspects of state income tax compliance activities including state income and franchise tax returns, determining estimated taxes and managing extension filings; oversee the Sales and Use tax team and all aspects of compliance, audit and operations.
  • Manage state income, franchise, and Sales and Use tax audits and notices, in close collaboration with internal and external tax controversy teams.
  • Review and approve actual and projected state income tax provisions, including state UTPs, valuation allowances return to provision reconciliations, and cash taxes, for completeness and accuracy.
  • Manage and review support for financial statement disclosures.
  • Oversee maintenance of SOX controls related to state and local tax processes to ensure compliance with Sarbanes-Oxley Act, provide support for testing and reviewing of non state and local tax controls.
  • Collaborate with various functions of the company to minimize state and local tax liability and reduce audit risk, and work with our Tax Planning Team and outside advisors on state tax planning opportunities.
  • Identify strategic streamlining opportunities for people, process and technology to drive efficiencies while maintaining integrity and robustness of the state and local tax compliance function.
  • Monitor tax legislative developments and work closely with tax planning team and government affairs.
  • Lead and mentor a team of tax professionals, providing guidance and support to develop staff and ensure high performance.
Desired Qualifications
  • Knowledge of TaxStream is very beneficial.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery accelerates BMS's R&D, improving drug development efficiency.
  • BMS's acquisition of 2seventy bio enhances its cancer cell therapy capabilities.
  • Positive Phase 3 trial results for Sotyktu boost BMS's psoriatic arthritis treatment portfolio.

What critics are saying

  • Increased competition in oncology may impact BMS's market share.
  • Layoffs could decrease employee morale, affecting operational efficiency.
  • Integration challenges from acquiring 2seventy bio may pose financial risks.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company integrates AI in early lung cancer diagnosis, enhancing precision care.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

European HHHM
Apr 16th, 2025
Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis

Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has entered an agreement with Bristol Myers Squibb (NYSE: BMY), to leverage AI in early diagnosis and precision lung cancer care.

CMMB
Mar 24th, 2025
Our Values, Your Impact

In partnership with Bristol Myers Squibb, Catholic Medical Mission Board Inc. is playing a role in building the infrastructure and workforce to bring quality cancer care to rural Kenya.

PR Newswire
Mar 20th, 2025
Bristol Myers Squibb Appoints Osama Braiwish As General Manager For Saudi Arabia Gulf Countries

RIYADH, Saudi Arabia, March 20, 2025 /PRNewswire/ -- Bristol Myers Squibb, a leading global biopharmaceutical company, has recently appointed Osama Braiwish as its General Manager for Saudi Arabia and Gulf Countries, an affiliate covering Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman, Bahrain, and Jordan

Investors Hangout
Mar 20th, 2025
Bristol Myers Squibb Welcomes New Leadership in Gulf Region

Bristol Myers Squibb, a leader in the global biopharmaceutical sector, has appointed Osama Braiwish as its General Manager for the Gulf region, thereby enhancing its capacity to serve medical needs across various specialties.

Business Wire
Mar 12th, 2025
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all